TNNI3 and metabolic dysfunction-associated steatohepatitis: As shown in Table 2, cardiotoxicity has been significantly associated with NASH in our untreated NASH group, with increased serum CK-MB levels, serum LDH levels and serum cTnI levels by 37%, 61% and 103%, respectively, in comparison to the control group.